Literature DB >> 25960834

The metabolic syndrome and inflammation: 
role of insulin resistance and increased adiposity.

Wajiha Farooq1, Umme Farwa1, Faisal Rashid Khan2.   

Abstract

OBJECTIVES: We sought to determine the role of obesity and insulin resistance (IR) in the pathogenesis of inflammation in metabolic syndrome (MetS).
METHODS: Our study included 100 patients with MetS and 100 age and gender matched control patients who attended a tertiary care laboratory in Rawalpindi, Pakistan. Anthropometric data was obtained including height and weight to calculate body mass index. A record of patient's blood pressure (BP), waist circumference (WC) and hip circumference (HC) was made. Biochemical analysis included measurements of fasting glucose, triglycerides (TG), high-density lipoprotein cholesterol (HDL-c), insulin, and high-sensitivity C reactive protein (hsCRP). IR was determined by the homeostasis mode assessment insulin resistance (HOMA-IR) method.
RESULTS: The levels of hs-CRP were found to be elevated in all patients with MetS where it correlated significantly with all its components including measures of obesity, fasting insulin and glucose levels, IR, TG and HDL-c. However, on linear regression analysis only WC, fasting insulin, and HOMA-IR remained significantly correlated with hs-CRP.
CONCLUSION: MetS is a condition characterized by chronic low-grade inflammation, which arises because of increased abdominal adiposity and IR. Large multicenter studies are needed to gain insight into its pathogenesis and derive treatment strategies.

Entities:  

Keywords:  Inflammation; Insulin Resistance; Metabolic Syndrome; Obesity

Year:  2015        PMID: 25960834      PMCID: PMC4412452          DOI: 10.5001/omj.2015.22

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  20 in total

Review 1.  Dairy components and risk factors for cardiometabolic syndrome: recent evidence and opportunities for future research.

Authors:  Beth H Rice; Christopher J Cifelli; Matthew A Pikosky; Gregory D Miller
Journal:  Adv Nutr       Date:  2011-09-06       Impact factor: 8.701

Review 2.  Pre-diabetes, metabolic syndrome, and cardiovascular risk.

Authors:  Scott M Grundy
Journal:  J Am Coll Cardiol       Date:  2012-02-14       Impact factor: 24.094

Review 3.  The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus.

Authors:  Henry N Ginsberg; Paul R MacCallum
Journal:  J Cardiometab Syndr       Date:  2009

4.  Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study.

Authors:  Giovanni Zuliani; Stefano Volpato; Matteo Galvani; Alessandro Blè; Stefania Bandinelli; Anna Maria Corsi; Fulvio Lauretani; Marcello Maggio; Jack M Guralnik; Renato Fellin; Luigi Ferrucci
Journal:  Atherosclerosis       Date:  2008-08-12       Impact factor: 5.162

5.  Inflammation as a Link between Obesity and Metabolic Syndrome.

Authors:  Faloia Emanuela; Michetti Grazia; De Robertis Marco; Luconi Maria Paola; Furlani Giorgio; Boscaro Marco
Journal:  J Nutr Metab       Date:  2012-03-01

6.  Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs.

Authors:  Mohamed Abu-Farha; Kazem Behbehani; Naser Elkum
Journal:  Cardiovasc Diabetol       Date:  2014-04-09       Impact factor: 9.951

7.  Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus.

Authors:  Zaid Al-Hamodi; Molham Al-Habori; Ali Al-Meeri; Riyadh Saif-Ali
Journal:  Diabetol Metab Syndr       Date:  2014-09-16       Impact factor: 3.320

8.  C-reactive protein, fibrinogen, and cardiovascular disease prediction.

Authors:  Stephen Kaptoge; Emanuele Di Angelantonio; Lisa Pennells; Angela M Wood; Ian R White; Pei Gao; Matthew Walker; Alexander Thompson; Nadeem Sarwar; Muriel Caslake; Adam S Butterworth; Philippe Amouyel; Gerd Assmann; Stephan J L Bakker; Elizabeth L M Barr; Elizabeth Barrett-Connor; Emelia J Benjamin; Cecilia Björkelund; Hermann Brenner; Eric Brunner; Robert Clarke; Jackie A Cooper; Peter Cremer; Mary Cushman; Gilles R Dagenais; Ralph B D'Agostino; Rachel Dankner; George Davey-Smith; Dorly Deeg; Jacqueline M Dekker; Gunnar Engström; Aaron R Folsom; F Gerry R Fowkes; John Gallacher; J Michael Gaziano; Simona Giampaoli; Richard F Gillum; Albert Hofman; Barbara V Howard; Erik Ingelsson; Hiroyasu Iso; Torben Jørgensen; Stefan Kiechl; Akihiko Kitamura; Yutaka Kiyohara; Wolfgang Koenig; Daan Kromhout; Lewis H Kuller; Debbie A Lawlor; Tom W Meade; Aulikki Nissinen; Børge G Nordestgaard; Altan Onat; Demosthenes B Panagiotakos; Bruce M Psaty; Beatriz Rodriguez; Annika Rosengren; Veikko Salomaa; Jussi Kauhanen; Jukka T Salonen; Jonathan A Shaffer; Steven Shea; Ian Ford; Coen D A Stehouwer; Timo E Strandberg; Robert W Tipping; Alberto Tosetto; Sylvia Wassertheil-Smoller; Patrik Wennberg; Rudi G Westendorp; Peter H Whincup; Lars Wilhelmsen; Mark Woodward; Gordon D O Lowe; Nicholas J Wareham; Kay-Tee Khaw; Naveed Sattar; Chris J Packard; Vilmundur Gudnason; Paul M Ridker; Mark B Pepys; Simon G Thompson; John Danesh
Journal:  N Engl J Med       Date:  2012-10-04       Impact factor: 91.245

9.  Impact of diabetes on cardiovascular disease: an update.

Authors:  Alessandra Saldanha de Mattos Matheus; Lucianne Righeti Monteiro Tannus; Roberta Arnoldi Cobas; Catia C Sousa Palma; Carlos Antonio Negrato; Marilia de Brito Gomes
Journal:  Int J Hypertens       Date:  2013-03-04       Impact factor: 2.420

Review 10.  Visceral adiposity index: an indicator of adipose tissue dysfunction.

Authors:  Marco Calogero Amato; Carla Giordano
Journal:  Int J Endocrinol       Date:  2014-04-14       Impact factor: 3.257

View more
  6 in total

1.  Association of FTO rs9939609 SNP with Obesity and Obesity- Associated Phenotypes in a North Indian Population.

Authors:  Jai Prakash; Balraj Mittal; Apurva Srivastava; Shally Awasthi; Neena Srivastava
Journal:  Oman Med J       Date:  2016-03

2.  Prevalence of Metabolic Syndrome in Patients with Schizophrenia Referred to Farabi Hospital, Kermanshah, Iran.

Authors:  Jalal Shakeri; Kamyar Karimi; Vahid Farnia; Senobar Golshani; Mostafa Alikhani
Journal:  Oman Med J       Date:  2016-07

3.  Effects of ovariectomy and intrinsic aerobic capacity on tissue-specific insulin sensitivity.

Authors:  Young-Min Park; R Scott Rector; John P Thyfault; Terese M Zidon; Jaume Padilla; Rebecca J Welly; Grace M Meers; Matthew E Morris; Steven L Britton; Lauren G Koch; Frank W Booth; Jill A Kanaley; Victoria J Vieira-Potter
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-08       Impact factor: 4.310

4.  Diets along with interval training regimes improves inflammatory & anti-inflammatory condition in obesity with type 2 diabetes subjects.

Authors:  Mahmoud Asle Mohammadi Zadeh; Mehdi Kargarfard; Syed Mohamad Marandi; Abdolhamid Habibi
Journal:  J Diabetes Metab Disord       Date:  2018-11-28

5.  Total Antioxidant Capacity from Dietary Supplement Decreases the Likelihood of Having Metabolic Syndrome in Korean Adults.

Authors:  Subeen Kim; YoonJu Song; Jung Eun Lee; Shinyoung Jun; Sangah Shin; Gyung-Ah Wie; Yoon Hee Cho; Hyojee Joung
Journal:  Nutrients       Date:  2017-09-22       Impact factor: 5.717

6.  Association of Dietary Patterns with Components of Metabolic Syndrome and Inflammation among Middle-Aged and Older Adults with Metabolic Syndrome in Taiwan.

Authors:  Ahmad Syauqy; Chien-Yeh Hsu; Hsiao-Hsien Rau; Jane C-J Chao
Journal:  Nutrients       Date:  2018-01-29       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.